Drug therapy of heart disease in pediatric patients. II. The treatment of congestive heart failure in infants and children with digitalis preparations.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002462:Cell Membrane / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D004070:Digitalis / Q000506:poisoning / Q000633:toxicity; D004071:Digitalis Glycosides / Q000627:therapeutic use*; D004077:Digoxin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy; D007674:Kidney Diseases / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012964:Sodium / Q000494:pharmacology; D014316:Tritium
D004071:Digitalis Glycosides; D014316:Tritium; D010042:Ouabain; D004077:Digoxin; D012964:Sodium; D000251:Adenosine Triphosphatases; D002118:Calcium